[1]
Cheng JY,Filippov G,Moline M,Zammit GK,Bsharat M,Hall N, Respiratory safety of lemborexant in healthy adult and elderly subjects with mild obstructive sleep apnea: A randomized, double-blind, placebo-controlled, crossover study. Journal of sleep research. 2020 Mar 18; [PubMed PMID: 32187781]
[3]
Rhyne DN,Anderson SL, Suvorexant in insomnia: efficacy, safety and place in therapy. Therapeutic advances in drug safety. 2015 Oct; [PubMed PMID: 26478806]
[4]
Sakurai T,Amemiya A,Ishii M,Matsuzaki I,Chemelli RM,Tanaka H,Williams SC,Richardson JA,Kozlowski GP,Wilson S,Arch JR,Buckingham RE,Haynes AC,Carr SA,Annan RS,McNulty DE,Liu WS,Terrett JA,Elshourbagy NA,Bergsma DJ,Yanagisawa M, Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell. 1998 Feb 20; [PubMed PMID: 9491897]
[5]
Peyron C,Tighe DK,van den Pol AN,de Lecea L,Heller HC,Sutcliffe JG,Kilduff TS, Neurons containing hypocretin (orexin) project to multiple neuronal systems. The Journal of neuroscience : the official journal of the Society for Neuroscience. 1998 Dec 1; [PubMed PMID: 9822755]
[6]
Asnis GM,Thomas M,Henderson MA, Pharmacotherapy Treatment Options for Insomnia: A Primer for Clinicians. International journal of molecular sciences. 2015 Dec 30; [PubMed PMID: 26729104]
[7]
Murphy P,Moline M,Mayleben D,Rosenberg R,Zammit G,Pinner K,Dhadda S,Hong Q,Giorgi L,Satlin A, Lemborexant, A Dual Orexin Receptor Antagonist (DORA) for the Treatment of Insomnia Disorder: Results From a Bayesian, Adaptive, Randomized, Double-Blind, Placebo-Controlled Study. Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine. 2017 Nov 15; [PubMed PMID: 29065953]
[8]
Fluyau D,Revadigar N,Manobianco BE, Challenges of the pharmacological management of benzodiazepine withdrawal, dependence, and discontinuation. Therapeutic advances in psychopharmacology. 2018 May; [PubMed PMID: 29713452]
[10]
Rosenberg R,Murphy P,Zammit G,Mayleben D,Kumar D,Dhadda S,Filippov G,LoPresti A,Moline M, Comparison of Lemborexant With Placebo and Zolpidem Tartrate Extended Release for the Treatment of Older Adults With Insomnia Disorder: A Phase 3 Randomized Clinical Trial. JAMA network open. 2019 Dec 2; [PubMed PMID: 31880796]